Pharma Leaders Forums - GMT (Greenwich Mean Time, GMTZ)
Morning Session. Chaired private and exclusive roundtable series.
11.10am (1hr 40mins) Roundtable One
- M&A, deal environment, anti-trust landscape analysis, general discussion and peer commentary from BD heads
11am Introductions
11.15 Current and Impending Anti-trust and Regulatory Threats
General Discussion and Peer Perspectives
- Perceptions and perspectives on current deal making environment: what are BD heads observing and how are they responding?
- How should big pharma M&A strategies evolve given the regulatory and anti-trust context?
For further information regarding the Pharma BD Leaders Forum, please contact:
Matthew Pullan, Managing Director, LSX
2pm (1hr 40 mins) Roundtable Two – Global BD Heads only
Pier discussion and exploration of solutions to presented challenges.
Potential topics to include:
- IRA developments
- M&A landscape
- Current challenges and success stories
- Anti-trust
- Regulatory update
- AI and relevance, impact on dealmaking
For further information regarding the Pharma BD Leaders Forum, please contact:
Matthew Pullan, Managing Director, LSX
Leaders Forums
Join leaders from Pharma and MedTech in an exclusive roundtable to shape the future of healthcare based on vectors of change related to connected health, policy, and care providers. Over the past 3 years, Pharma invested heavily in introducing new connected health solutions to patients and population level predictive technologies. However, Pharma can't take responsibility for the entire care pathway. Last mile and integrated care remain complex problems, disconnected from the current business model. Meanwhile, the health ecosystem keeps diversifying, further fragmenting care, platforms, and data.
In this invite-only round table, we will explore four disruptive scenarios and their impact on the healthcare systems’ actors, tackle big questions and pinpoint the critical decisions needed today to navigate tomorrow’s challenges:
- Who will own the patient and the physician relationships?
- Where does the balance lie between prevention and acute care?
- Is the promise of digital health really here?
- Is precision health the next goal; is it achievable?
- How will these initiatives be funded considering the business models today?
- Who will be the disruptors in these futures? Where will they play and make their foothold?
- What will be Pharma and MedTech makers’ key challenges in these futures and how to overcome them?
Facilitated by a unique future-casting methodology by frog, this debate will bring diverse perspectives from Pharma and MedTech leaders to explore and resolve these tensions.
- Ross Landles - Global Head of Portfolio, frog
- Sofia Loreto - Design & UX Strategy Director, and Life Sciences Sector Lead, frog
- Jen Berkeley - Design Director, Frog UK